Dark Horse Consulting Expands Asia with CJ PARTNERS Deal

Walnut Creek, California & Tokyo, Japan, April 21, 2026

In a strategic move to strengthen its global consulting footprint in the biopharma sector, Dark Horse Consulting Group (DHCG) has announced the acquisition of CJ PARTNERS (CJP), a specialized advisory firm focused on cross-border regulatory strategy and clinical operations in Japan. This acquisition significantly enhances DHCG’s capabilities in the Asia-Pacific region, particularly in navigating the complex Japanese regenerative medicine and life sciences market. By integrating CJP’s expertise, DHCG aims to deliver end-to-end consulting solutions that support global biotech companies in accelerating development, reducing entry risk, and maximizing commercialization opportunities across international markets.

Strengthening Cross-Border Biopharma Capabilities

The acquisition of CJ PARTNERS represents a critical step in DHCG’s strategy to build a globally integrated consulting ecosystem. CJP has established itself as a key player in bridging the gap between Western and Eastern therapeutic developers, working closely with stakeholders such as regulators, including Japan’s PMDA, investors, and commercial partners. Its services span market analysis, strategic partnerships, regulatory advisory, and clinical operations, making it a valuable addition to DHCG’s expanding portfolio.

Notably, CJP brings a unique capability as a trial secretariat and in-country clinical caretaker, enabling efficient execution of clinical trials in Japan for both domestic and international sponsors. This integration enhances DHCG’s ability to provide localized expertise with global reach, a critical factor in today’s increasingly interconnected biopharmaceutical landscape.

Expanding Presence in Japan’s Regenerative Medicine Market

Japan has emerged as a global leader in regenerative medicine, supported by progressive regulatory frameworks introduced in recent years. CJ PARTNERS has built a strong reputation in this space by helping biotech companies navigate Japan’s unique regulatory and commercial environment, particularly following the introduction of regenerative medicine laws in 2014. The firm’s bi-cultural and bilingual expertise enables seamless collaboration between Japanese and international stakeholders, facilitating smoother market entry and operational execution.

By acquiring CJP, DHCG gains direct access to this specialized knowledge base, positioning itself as a preferred partner for companies seeking to expand into Japan and broader Asian markets. This move also enables Japanese pharmaceutical companies to access global innovation pipelines, fostering two-way collaboration and accelerating the development of cutting-edge therapies.

Strategic Growth and Industry Impact

The transaction underscores DHCG’s commitment to addressing the growing demand for integrated consulting services across the biopharma lifecycle, from early discovery to commercialization. With the addition of CJ PARTNERS, DHCG strengthens its ability to provide white-glove consulting services backed by deep expertise in regulatory affairs, manufacturing, quality, clinical development, and commercialization strategy.

This acquisition aligns with broader industry trends where companies are seeking holistic, globally coordinated solutions to overcome scientific, regulatory, and market access challenges. Furthermore, the deal enhances DHCG’s competitive positioning in the rapidly evolving cell and gene therapy and regenerative medicine sectors, where cross-border collaboration is essential for success. As highlighted in the announcement, this expansion reflects DHCG’s long-term vision of becoming a leading global consultancy capable of supporting clients in solving complex challenges across diverse geographies and therapeutic areas.

Overall, the acquisition of CJ PARTNERS marks a pivotal milestone for Dark Horse Consulting Group, reinforcing its role as a global enabler of innovation in the life sciences industry. By combining regional expertise with global capabilities, DHCG is well-positioned to drive accelerated development, regulatory success, and commercial growth for its clients worldwide.

Source: Dark Horse Consulting Group, CJ PARTNERS press release